pre-miRNA Information | |
---|---|
pre-miRNA | hsa-let-7a-1 |
Genomic Coordinates | chr9: 94175957 - 94176036 |
Synonyms | LET7A1, MIRNLET7A1, let-7a-1, MIRLET7A1 |
Description | Homo sapiens let-7a-1 stem-loop |
Comment | let-7a-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
pre-miRNA | hsa-let-7a-3 |
Genomic Coordinates | chr22: 46112749 - 46112822 |
Synonyms | LET7A3, MIRNLET7A3, let-7a-3, MIRLET7A3 |
Description | Homo sapiens let-7a-3 stem-loop |
Comment | let-7a-3p cloned in has a 1 nt 3' extension (U), which is incompatible with the genome sequence. |
RNA Secondary Structure | ![]() |
Associated Diseases | ![]() |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-let-7a-3p | |||||||||||||||||||||||||||||||||||||||
Sequence | 57| CUAUACAAUCUACUGUCUUUC |77 | |||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||
Experiments | Cloned | |||||||||||||||||||||||||||||||||||||||
Editing Events in miRNAs |
|
|||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TRIM33 | ||||||||||||||||||||
Synonyms | ECTO, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA | ||||||||||||||||||||
Description | tripartite motif containing 33 | ||||||||||||||||||||
Transcript | NM_015906 | ||||||||||||||||||||
Other Transcripts | NM_033020 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TRIM33 | |||||||||||||||||||||
3'UTR of TRIM33 (miRNA target sites are highlighted) |
>TRIM33|NM_015906|3'UTR 1 AATGACATGGATTTAAATCAATTGTTTAAAAAAAAAAAAACGAAAAAAAAAAAAAAAACACAAAAAACCCAGAAAACTTT 81 TAAGTGTTGCTGGAATATCCTGCCTACAGTGGGCACCTCCTTGAAGAAGCTGATAGCTTTTACACAGTATTAGATTGAAA 161 TAATGGACAGAAACACATTCTTGTCAAGAAAGGGGGAGAGAAGTCTGTTTGCAAGTTTCAAAGCAAAAAGCAAAAGTGAA 241 ATGATTTGAGGATTTCTGTTCTAATGGAGATGATTCTCTGATTGTTAGAAATGGCAAATATTGATGATTGTGTGCTATTG 321 ATTGGTGCAGGATACTTGGTATACGAGTAAATACTTGAGACTCGTGTCACTTGATAAATTTTCTTTTTGGACTAGGTCGC 401 ACAGTTATTAAAACAACTTTTAACCCTCCCCCTTCACACACATACATATCAGGTTGTTTTCTAGTTAAAAACCCAAGTAG 481 CTCAGATTCTACTTTAATGTCAGTGCAGATTTGCATTGAATCATGCCATTATGTTTTTTCTCATTTTTATGCTGTTGGGT 561 CTTAGTTTTTAAATTGATATAAAGAACTCAGCAATGGTTTTATTTTCTACTCATACTTAGGGTTTAGGAAACACTACCAC 641 TAGTTATCATTTAATCAACTTCAATGGTCTACTGAAACAAAAATGGTAACTTTTCATTAGTGGATTATTTAGAGTTATAG 721 TAGTTGTTTCCAGAAAACACTTCCTCACAATTGTACTTCCCAATCAAATCATGTGATCATACAGTTATTCCCATGAAAGG 801 CAGAATGTTTGTTTCAAAATTAATCTAGTTTTCTGTACATTTAAATTTGAGAAGGTGACAACTGGCTCTTTTCCAGTCTT 881 CCTTCATGTCAGTTTTCTGATAGACCACTATTGGCAAACAGTATCTGTCAACTACCAAATGTGTAAAATTTTCTGTATTT 961 CACTTTGTCTTATTTGTAAATAGTGAACTAAAACTTTTGGCAGATCAGCAACATTTGCTGAGCCTGTTTTTTAAGCTAAT 1041 GTGTATTCTTACTAATGTTCCTATCAAGAATGGATTTGTAATATATGCTGTCTATTTCTAATGTTCACATTCATATTTTG 1121 AGGTTCTATCTTATTTTAATAGAGAACAGACTTCTCAAAAAATCTTCAGAAGCAGCTTATTATTGAAATATCGAAATATT 1201 GAAATAAACCCGGTGGGGTTAGATTACTCATCTGTCCACCAAGTGGGACATTTGCATGGACTGGGGGCTTAAAGGACTTA 1281 GAAGAGACCTGTAAGTAAATCCTGAAAATGAGCCAATCCCCACTTGAATGGTTACTGGAGTAAACCCACCTTTACCACCC 1361 CAATTACAGCACCCGAGGCCGATAAACCAACTTGGCTCTGGTTCATTTTTCTTTTCTTCATTTGTGATGCTCAGATTCAA 1441 AATGTGTGTTCTACACTGTTACAGGCTTCTCTTTTGTTTGATTAAAGATTTTAGTCCTACTTTTGTATGGACACATTAGA 1521 ATATTCAGAGACCAAAATAGAAGAATTTGCTGTTAGATATTTTTCAGAAGTCAGCAGATTTGTGGCAAATCATTTATTTG 1601 CCTTTTTAAAAATTCATTTAAGCAGTTCAGAGAGTAGACTACTCAGAAAATTATTTCACGTAATTGTCTAAGAGGTCAAT 1681 ATTTTTTAATGCATATTGAATCAAATAAAGTGCTCTAAAGAAATTATTATACAAATTCCTTTGGGTTGTTTTTCTTTTCT 1761 TAACAAGGGGTGGGGGTAAACAGGAATATGATTCAGGCTTTCTGGTTGTGTATTTAAAGAGTATTGATTTTATTATTACT 1841 ATTGATTTACTTTATTCCTGGCTTCCTTTTCACTTTTCTTTCAATTTTTAAAAAATAATTTAAGCCGTTGAAAATATACC 1921 AAACTGTTGAAACATTTTACTCAAATTTTAAATTCCTAAAAATGTTTTTTAATAAGAGGGAGAAAATTATTTAAAAATAC 2001 TTATGCCTATGCCAATTTCCCTCTTTTTTCACAAAATCCATGATTTCAGTTTGTAAGTAGACATATATCTAAGGGCACAT 2081 TTTTGGAAAGTGAGGAATAGCAGCAGTATAACTTCATTTTGTCAGGCCTTTGAGTTCTAATATTTTGTATTGCTCTTCAA 2161 ATGGATCCTTTTAAAAAAATTGTAGATAATGAGTCATAAATAGATTCTGCCAACTGAGGGGAGAAACATTTTAAGTAAAT 2241 ATTTTTCAGTATTTGGGGCCTTAAAAAATAATTGTGTTTCCTTAAAATTACATGTTAGATAGAGTTTTTAGGTTTTTTTG 2321 GTTTTAAGATTGGTTAAAGCAATTTAAAAGCCACTTTTTTGTCAACATTTAATAGCCTCCACTTCTGTTAAGATAATGTA 2401 TACTGCTGAGGAATTACTATTAATAGCTATCAACATACCACCATTAAATTAAGGTATTCACTTTAGATTTTTTATTAAAG 2481 CTTTTTTCTTGCACACTGATCGTTGTGTTTCTAAGCTGATTTTTTCAGCTCTAATATACCTATGGTTAAAAAGTATAAAA 2561 ACTTAAATTGATATTTAGATATATGTTTTCCTATTAGTTTATGTTTTAAAAAGACAAAATTGTATCTGTCAGTCCCTGAA 2641 GGCAGTTTGTTTTTATACTCTCTCACATTTGTATTTGTTTTTTAAATGGCAGTATTTTAGAAGATTTGGAGAAAAGTCCA 2721 CATAATAATGTTTTCTTAAAAGCTTTTAAAGTTTTTGCTGTACTTCAATTTACTTCTTCCATCAGAAAACTAAGAACAAA 2801 GTGTTGCTCAGTCTGTTCCGCTGACCTAAATTTGTGTTTTCAGCACTTGGCTCAGCCAATTCACTGAGTGAAGGAATTGC 2881 TTTATGAGGCAAAGCATGTGAAAGTTCTAAAGTATGGTTAGATTGTAGGTCGTGCTCTATATGGAAACATCAAACCATTA 2961 CTACAGAGAAATGATAAGGCATTGGATCCACTATTGAAATTATTATTTTTGGATCAACAAGTTGGTACTTTCTGACTTCT 3041 GTATCTTAACATAAGGGAATTTTAGGTAATGCTAAGTCAGTTGTCTCATTTTTTGTGATAAGTTTTGGAATTTTTAGTTA 3121 ATTGAAATAAATAATGCTTTTAAATAGAAGTAAAAGGTTTATAAGTGTGCAAATTGTAGATTTATCAATTACCTCAGCAG 3201 GTATCCTGCCATGTAATTATTAGTGATTAGTGTTAATAAGATAATAGATTCAGGTCTTCCAACTATGCCCTTGGATTGTG 3281 GCCTACTGTATGTTATTAAATGGTCTCTTACTATCCAAAATGGGAGTAGATGCTGTGGCCCCGTCTCCCTTGGCTTTTAC 3361 GTCCCATATCCACCCCCATTCATGTACAACATGTGAAATATAAAAATCTCATTTCTTGTCAAAATCAGCACTGCTTATTT 3441 GCATACTCAGCATCGGATCAGTGAGTAGTTTTATAAAAAATCCACGCACCCAACTCCCTTAGTTAAAACAGATTCTTAAT 3521 TCATACCATGAATTCTTAATTTCTGTACCATCTATGTTAATGATCTGCTGAAGGTGACTCAAGATTTTCAAGGTGTAATA 3601 CAGTTTGATCATGTACCGGACCTGGATATTTAATTTTTTTTCCCTCACAGTTAATCTCCTCCTTGATAAAGCAATAACAC 3681 TGCTTTGAGTCTGTTGCCTAATAGCATGTCAGAATCCTCTCCTGGATGGTGATTTTATAGGAAAGTTTGTATGCATATCA 3761 CCCAGTCTATCTTTTAAAAATTAAGAAATTTAAATGTATGCTGGAAGTAATGACACTATATTGTGGCATTTTATTTTAAA 3841 AATTGGGGAAAGTTGCATATTTTTTTAAAAGTAAGTGTTTGAGTAAAAAAATTGAAGGTACTTTTTTAAGGAAAAAAATT 3921 TATATGCCACAGTTTACATAGACATTTCAGATTCAACACGTACTCTTGAATATAATGGTTTCTTTTACTTGGTCAAAATG 4001 CATGTATAGCATTTCTTTCATCTTAGTTCCTTGTGTTTGCCTATGTGGTCCTTTATATATTTTTTATTGTATCGAAGAAA 4081 CAAAACTATCTTCAAAAATAAGTTAATTTGGATATATTTGTCATATCAAACTACAAAGTGTACAAAGTTAAGTTTAGCCC 4161 TTTTCTAGAAAGTGATCTTTAAAATTAAAAATGCTCCTCTTTTAAATTCACCAAATTTATGTGTGGGAAGGCACCAAAAT 4241 GATTTTGTAAGTGCCACTGCAATATTCCCTTTCAAGTGTGGCCTAAATTTCAATCTTAAGGATGGAATGCATGTCTGCTC 4321 CTTGTTCTGAAAAATGTAGGCATCTACTACATTTTAAAACACAGTGAAACATATACATAAGCCTATAAAAAAAGATTTGT 4401 GCAATTTGAAAGCCTGTTAATTTTTTATGTAGACATACCTACACACGAAAGGGTTAAATTCACAGCCTTACTAGTTCCTT 4481 GCTTCCAGTATTTCAATTGGTCTCCTCCCCTCATTATTATTATTACTACTAGTACTATTATTTTTGCACATAGTTAACTG 4561 CCCTTCAATATGATTCTTAAAAAGTGCTGTTTCTGTGGTATCGTATTCTCTAAATAATCATATTTAATTTTTTAAAACAA 4641 GGTTGCAGTTTCTAATTGTTTCGTTCCTGTGTTTTTGCTGGTGTGTAATAAAAGCAAGTTTTTTCTTTTCATGGTTATTT 4721 AATACATTAGCTGCCTGTAAATAATTCTTGTTATAATGCTCTGGAATGTGTTGTAGAAGTTGTATTAGATTAGTTTTAAA 4801 CCCTTGTTTGAAAGCCACATTGTTTTGGTTATTTCTATTAAATTAGAAAATTGAAAAAGTTTTCAAATGAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Flp-In T-REx 293-hAGO1 cells | ||||||
Location of target site | CDS | ||||||
Original Description (Extracted from the article) |
...
Validation of interactions identified by CLASH suppports their reliability.
... - Helwak A; Kudla G; Dudnakova T; Tollervey D, 2013, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Helwak A; Kudla G; Dudnakova T; Tollervey D - Cell, 2013
MicroRNAs (miRNAs) play key roles in gene regulation, but reliable bioinformatic or experimental identification of their targets remains difficult. To provide an unbiased view of human miRNA targets, we developed a technique for ligation and sequencing of miRNA-target RNA duplexes associated with human AGO1. Here, we report data sets of more than 18,000 high-confidence miRNA-mRNA interactions. The binding of most miRNAs includes the 5' seed region, but around 60% of seed interactions are noncanonical, containing bulged or mismatched nucleotides. Moreover, seed interactions are generally accompanied by specific, nonseed base pairing. 18% of miRNA-mRNA interactions involve the miRNA 3' end, with little evidence for 5' contacts, and some of these were functionally validated. Analyses of miRNA:mRNA base pairing showed that miRNA species systematically differ in their target RNA interactions, and strongly overrepresented motifs were found in the interaction sites of several miRNAs. We speculate that these affect the response of RISC to miRNA-target binding.
LinkOut: [PMID: 23622248]
|
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
121 hsa-let-7a-3p Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT038998 | ARMC8 | armadillo repeat containing 8 | ![]() |
1 | 1 | |||||||
MIRT038999 | SETD4 | SET domain containing 4 | ![]() |
1 | 1 | |||||||
MIRT039000 | BTF3 | basic transcription factor 3 | ![]() |
1 | 1 | |||||||
MIRT039001 | MIPOL1 | mirror-image polydactyly 1 | ![]() |
1 | 1 | |||||||
MIRT039002 | TRIM33 | tripartite motif containing 33 | ![]() |
1 | 1 | |||||||
MIRT039003 | CS | citrate synthase | ![]() |
1 | 1 | |||||||
MIRT039004 | SENP7 | SUMO1/sentrin specific peptidase 7 | ![]() |
1 | 1 | |||||||
MIRT055418 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | ![]() |
![]() |
2 | 10 | ||||||
MIRT057681 | LCOR | ligand dependent nuclear receptor corepressor | ![]() |
![]() |
2 | 8 | ||||||
MIRT061351 | WEE1 | WEE1 G2 checkpoint kinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT062174 | WNK1 | WNK lysine deficient protein kinase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT071813 | RNF11 | ring finger protein 11 | ![]() |
![]() |
2 | 2 | ||||||
MIRT091374 | EIF4A2 | eukaryotic translation initiation factor 4A2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT095107 | SEC24A | SEC24 homolog A, COPII coat complex component | ![]() |
![]() |
2 | 2 | ||||||
MIRT098814 | PPIL4 | peptidylprolyl isomerase like 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT109534 | KLHL15 | kelch like family member 15 | ![]() |
![]() |
2 | 4 | ||||||
MIRT120263 | GSK3B | glycogen synthase kinase 3 beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT149839 | LDLR | low density lipoprotein receptor | ![]() |
![]() |
2 | 6 | ||||||
MIRT164519 | MSMO1 | methylsterol monooxygenase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT165879 | CREBRF | CREB3 regulatory factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT169899 | HBP1 | HMG-box transcription factor 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT182779 | TOR1AIP2 | torsin 1A interacting protein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT193466 | RORA | RAR related orphan receptor A | ![]() |
![]() |
2 | 2 | ||||||
MIRT226421 | TP53INP1 | tumor protein p53 inducible nuclear protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT334410 | CREBZF | CREB/ATF bZIP transcription factor | ![]() |
![]() |
2 | 6 | ||||||
MIRT338286 | SYF2 | SYF2 pre-mRNA splicing factor | ![]() |
![]() |
2 | 2 | ||||||
MIRT361627 | TES | testin LIM domain protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT406687 | ZNF181 | zinc finger protein 181 | ![]() |
![]() |
2 | 2 | ||||||
MIRT407768 | MRPL35 | mitochondrial ribosomal protein L35 | ![]() |
![]() |
2 | 2 | ||||||
MIRT449468 | HAT1 | histone acetyltransferase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT467110 | SRI | sorcin | ![]() |
![]() |
2 | 2 | ||||||
MIRT475099 | IRF2BP2 | interferon regulatory factor 2 binding protein 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT481671 | ARAP2 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493061 | MTFR1 | mitochondrial fission regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT497923 | BTG1 | BTG anti-proliferation factor 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT498202 | ACVR2B | activin A receptor type 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT503391 | ASB11 | ankyrin repeat and SOCS box containing 11 | ![]() |
![]() |
2 | 6 | ||||||
MIRT503862 | UBXN2B | UBX domain protein 2B | ![]() |
![]() |
2 | 2 | ||||||
MIRT504368 | ARID1B | AT-rich interaction domain 1B | ![]() |
![]() |
2 | 4 | ||||||
MIRT504991 | ZNF652 | zinc finger protein 652 | ![]() |
![]() |
2 | 2 | ||||||
MIRT505754 | SENP1 | SUMO1/sentrin specific peptidase 1 | ![]() |
![]() |
2 | 8 | ||||||
MIRT518102 | ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | ![]() |
![]() |
2 | 6 | ||||||
MIRT521930 | PHF8 | PHD finger protein 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT522139 | NRBF2 | nuclear receptor binding factor 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT522401 | MYADM | myeloid associated differentiation marker | ![]() |
![]() |
2 | 4 | ||||||
MIRT523593 | FZD5 | frizzled class receptor 5 | ![]() |
![]() |
2 | 4 | ||||||
MIRT523944 | E2F8 | E2F transcription factor 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT524355 | CREB1 | cAMP responsive element binding protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT525140 | ZNF256 | zinc finger protein 256 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527070 | ABCC4 | ATP binding cassette subfamily C member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT527486 | OCIAD1 | OCIA domain containing 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT528129 | PPP1R10 | protein phosphatase 1 regulatory subunit 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT530528 | ALG10B | ALG10B, alpha-1,2-glucosyltransferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT531270 | PPIL3 | peptidylprolyl isomerase like 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT538898 | BRI3BP | BRI3 binding protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT541371 | CDKN1B | cyclin dependent kinase inhibitor 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT541526 | MGAT4C | MGAT4 family member C | ![]() |
![]() |
2 | 2 | ||||||
MIRT543776 | RBM12B | RNA binding motif protein 12B | ![]() |
![]() |
2 | 4 | ||||||
MIRT543946 | NCOA7 | nuclear receptor coactivator 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT545156 | GABRG1 | gamma-aminobutyric acid type A receptor gamma1 subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT545848 | ZNF264 | zinc finger protein 264 | ![]() |
![]() |
2 | 4 | ||||||
MIRT546064 | VEZF1 | vascular endothelial zinc finger 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT546481 | SLC16A14 | solute carrier family 16 member 14 | ![]() |
![]() |
2 | 4 | ||||||
MIRT551835 | AASDHPPT | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | ![]() |
![]() |
2 | 2 | ||||||
MIRT551901 | ACP1 | acid phosphatase 1, soluble | ![]() |
![]() |
2 | 2 | ||||||
MIRT552490 | ZNF136 | zinc finger protein 136 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554206 | SLC35A5 | solute carrier family 35 member A5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT554295 | SIPA1L2 | signal induced proliferation associated 1 like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555765 | PCTP | phosphatidylcholine transfer protein | ![]() |
![]() |
2 | 2 | ||||||
MIRT558315 | DSG2 | desmoglein 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT563147 | NOLC1 | nucleolar and coiled-body phosphoprotein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT566464 | PGGT1B | protein geranylgeranyltransferase type I subunit beta | ![]() |
![]() |
2 | 2 | ||||||
MIRT567322 | HMGB2 | high mobility group box 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT567738 | DLX2 | distal-less homeobox 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT567892 | CSTF2 | cleavage stimulation factor subunit 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT570087 | KANSL1L | KAT8 regulatory NSL complex subunit 1 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT571136 | TTC33 | tetratricopeptide repeat domain 33 | ![]() |
![]() |
2 | 2 | ||||||
MIRT573534 | MDM2 | MDM2 proto-oncogene | ![]() |
![]() |
2 | 2 | ||||||
MIRT574465 | RPS16 | ribosomal protein S16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574998 | Phka1 | phosphorylase kinase alpha 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT610202 | CD99 | CD99 molecule (Xg blood group) | ![]() |
![]() |
2 | 4 | ||||||
MIRT612926 | GPRIN3 | GPRIN family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT615027 | DUSP6 | dual specificity phosphatase 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT617200 | GREM1 | gremlin 1, DAN family BMP antagonist | ![]() |
![]() |
2 | 2 | ||||||
MIRT628720 | ZNF585A | zinc finger protein 585A | ![]() |
![]() |
2 | 2 | ||||||
MIRT641491 | POLA2 | DNA polymerase alpha 2, accessory subunit | ![]() |
![]() |
2 | 2 | ||||||
MIRT641663 | PAPOLG | poly(A) polymerase gamma | ![]() |
![]() |
2 | 2 | ||||||
MIRT642216 | RUVBL2 | RuvB like AAA ATPase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT654589 | PURA | purine rich element binding protein A | ![]() |
![]() |
2 | 2 | ||||||
MIRT656136 | MSH6 | mutS homolog 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT656899 | KIAA2018 | upstream transcription factor family member 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660136 | BRPF3 | bromodomain and PHD finger containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT660861 | AFAP1 | actin filament associated protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT676849 | PHKA1 | phosphorylase kinase regulatory subunit alpha 1 | ![]() |
![]() |
2 | 3 | ||||||
MIRT681479 | DIP2A | disco interacting protein 2 homolog A | ![]() |
![]() |
2 | 2 | ||||||
MIRT682259 | RS1 | retinoschisin 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT685602 | MYOM2 | myomesin 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686943 | SFT2D3 | SFT2 domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694302 | COPB2 | coatomer protein complex subunit beta 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT694407 | ALDH1A3 | aldehyde dehydrogenase 1 family member A3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT697280 | ZNF800 | zinc finger protein 800 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698414 | TM4SF1 | transmembrane 4 L six family member 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT698989 | SPAG9 | sperm associated antigen 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699766 | SEMA4D | semaphorin 4D | ![]() |
![]() |
2 | 2 | ||||||
MIRT699928 | RUFY2 | RUN and FYVE domain containing 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702113 | MBNL1 | muscleblind like splicing regulator 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702373 | KLF10 | Kruppel like factor 10 | ![]() |
![]() |
2 | 2 | ||||||
MIRT702646 | ITGA3 | integrin subunit alpha 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT705713 | ANAPC16 | anaphase promoting complex subunit 16 | ![]() |
![]() |
2 | 2 | ||||||
MIRT717925 | ZNF546 | zinc finger protein 546 | ![]() |
![]() |
2 | 2 | ||||||
MIRT720839 | C1orf52 | chromosome 1 open reading frame 52 | ![]() |
![]() |
2 | 2 | ||||||
MIRT725033 | NDUFAF7 | NADH:ubiquinone oxidoreductase complex assembly factor 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT731448 | APOBEC3A | apolipoprotein B mRNA editing enzyme catalytic subunit 3A | ![]() |
1 | 1 | |||||||
MIRT733217 | CCNG1 | cyclin G1 | ![]() |
![]() |
2 | 0 | ||||||
MIRT734887 | LIN28B | lin-28 homolog B | ![]() |
1 | 0 | |||||||
MIRT735276 | HMGA2 | high mobility group AT-hook 2 | ![]() |
![]() |
2 | 0 | ||||||
MIRT735727 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | ![]() |
![]() |
![]() |
3 | 0 | |||||
MIRT736087 | RCVRN | recoverin | ![]() |
1 | 0 | |||||||
MIRT736088 | RHO | rhodopsin | ![]() |
1 | 0 | |||||||
MIRT736103 | TLR7 | toll like receptor 7 | ![]() |
1 | 0 | |||||||
MIRT736607 | TPO | thyroid peroxidase | ![]() |
![]() |
2 | 0 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|